1-10 of 10
Pamala A. Jacobson, PharmD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pre-Transplant Serum Claudin-3 Predicts Intestinal Graft-Versus-Host Disease and Non-Relapse Mortality Risk after Allogeneic Hematopoietic Cell Transplantation

Shernan Holtan, MD, Todd E. DeFor, MS, Armin Rashidi, MD PhD, Alexander Khoruts, MD, Christopher Staley, PhD, Lucie M Turcotte, MD, Pamala A. Jacobson, PharmD, Daniel J. Weisdorf, MD, Margaret L. MacMillan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 39.
https://doi.org/10.1182/blood-2019-129236
Published: 2019
Journal Articles

Facilitating Resolution of Life-Threatening Acute Graft-Versus-Host Disease By Supplementation of Human Chorionic Gonadotropin and Epidermal Growth Factor (Pregnyl): A Phase I Study

Shernan G. Holtan, MD, Andrea Hoeschen, Qing Cao, MS, Mukta Arora, MD, Veronika Bachanova, MD PhD, Claudio G Brunstein, MD PhD, Sarah Cooley, MD, Jeffrey S. Miller, MD, Arne Slungaard, MD, Celalettin Ustun, MD, Armin Rashidi, MD PhD, Gregory M Vercellotti, MD FACP, Erica D. Warlick, MD, Todd E. DeFor, MS, John E. Wagner, MD, Bruce R. Blazar, MD, Pamala A. Jacobson, PharmD, Angela Panoskaltsis-Mortari, PhD, Margaret L. MacMillan, MD, Daniel J. Weisdorf, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 71.
https://doi.org/10.1182/blood-2018-99-113564
Published: 2018
Journal Articles

Phosphoramide Mustard (PM) Population Pharmacokinetics to Estimate Inter-Individual Variability in Exposure and Identify Clinical Factors Associated with Variability in Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplant (HCT) Patients

Kinjal Sanghavi, M Pharm, Anthony C. Wiseman, MD, Mark Kirstein, PharmD, Richard Brundage, PharmD PhD, Pamala A. Jacobson, PharmD
Journal: Blood
Blood (2014) 124 (21): 2478.
https://doi.org/10.1182/blood.V124.21.2478.2478
Published: 2014
Journal Articles

Association of Cyclophosphamide (CY) and Fludarabine (FLU) Pharmacokinetics with Treatment Related Mortality (TRM) after Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplantation (HCT)

Anthony C. Wiseman, MD, Kinjal Sanghavi, M Pharm, Qing Cao, MS, Erica D. Warlick, MD, Claudio G Brunstein, MD, John Rogosheske, PharmD, Andy Kurtzweil, PharmD, Daniel J. Weisdorf, MD, Pamala A. Jacobson, PharmD
Journal: Blood
Blood (2014) 124 (21): 1153.
https://doi.org/10.1182/blood.V124.21.1153.1153
Published: 2014
Journal Articles

Pharmacokinetic Modeling of Fludarabine to Control Exposure and Improve Outcomes after Reduced Intensity Conditioning Transplantation

Kinjal Sanghavi, M Pharm, Anthony C. Wiseman, MD, Qing Cao, MS, Erica D. Warlick, MD, Claudio G Brunstein, MD, Richard Brundage, PharmD PhD, John Rogosheske, PharmD, Andy Kurtzweil, PharmD, John E. Wagner, MD, Daniel J. Weisdorf, MD, Pamala A. Jacobson, PharmD
Journal: Blood
Blood (2014) 124 (21): 3869.
https://doi.org/10.1182/blood.V124.21.3869.3869
Published: 2014
Journal Articles

Association Between Genetic Variants in Immune Response Genes and Outcomes After Hematopoietic Cell Transplantation

Bharat Thyagarajan, MD, PhD, Scott Jackson, MS, Saonli Basu, PhD, Pamala A. Jacobson, PharmD, Myron D Gross, PhD, Daniel J. Weisdorf, MD, Mukta Arora, MD
Journal: Blood
Blood (2011) 118 (21): 3049.
https://doi.org/10.1182/blood.V118.21.3049.3049
Published: 2011
Journal Articles

Comparison of Two Mycophenolate Mofetil Dosing Regimens Following Hematopoietic Cell Transplantation (HCT).

Pamala A. Jacobson, PharmD, Sheiren Farag El-Massah, John Rogosheske, PharmD, Amber Kerr, RN, Janel Boyle-Long, PharmD, Todd DeFor, MS, Cathryn Jennisen, PharmD, Claudio Brunstein, MD, John E. Wagner, MD, Marcie Tomblyn, MD, Daniel Weisdorf, MD
Journal: Blood
Blood (2008) 112 (11): 1116.
https://doi.org/10.1182/blood.V112.11.1116.1116
Published: 2008
Journal Articles

Fludarabine Exposure Is Associated with Increased Treatment Related Mortality after Nonmyeloablative Hematopoietic Cell Transplantation (HCT)

Pamala A. Jacobson, Pharmd, Janel R Long, PharmD, John Rogosheske, PharmD, Kathleen Green, PharmD, Claudio Brunstein, MD, John E Wagner, MD, Qing Cao, MS, Jeffrey S. Miller, MD, Philip McGlave, MD, Daniel Weisdorf, MD
Journal: Blood
Blood (2008) 112 (11): 795.
https://doi.org/10.1182/blood.V112.11.795.795
Published: 2008
Journal Articles

Higher Mycophenolate Dose Requirements in Children Undergoing Hematopoietic Cell Transplant (HCT).

Pamala A. Jacobson, PharmD, Jiayin Huang, MS, Nancy Rydholm, PharmD, MyHang Tran, PharmD, Todd DeFor, MS, Jakub Tolar, MD, PhD, Paul J. Orchard, MD
Journal: Blood
Blood (2007) 110 (11): 3011.
https://doi.org/10.1182/blood.V110.11.3011.3011
Published: 2007
Journal Articles

Fludarabine Pharmacokinetics in Nonmyeloablative Hematopoietic Cell Transplantation (HCT): Association with Engraftment and Neurotoxicty.

Pamala A. Jacobson, PharmD, John Rogosheske, PharmD, Kathleen Green, PharmD, Claudio Brunstein, MD, Juliet Barker, MD, Jeff Miller, MD, John Wagner, MD, Philip McGlave, MD, Ye Tan, MS, Daniel Weisdorf, MD
Journal: Blood
Blood (2005) 106 (11): 3673.
https://doi.org/10.1182/blood.V106.11.3673.3673
Published: 2005